Back to search
FDAFDA · Food and drugs·Recall number Z-0625-2024

Reverse Shoulder System e+, REF 509-01-032, RSP Humeral Socket Insert, Sz. 32mm, Semi-Constrained, Sterile H2o2, CE 2797

Published January 10, 2024 · Recall initiated: October 5, 2023

Summary

FDA records medical device Class II recall Z-0625-2024, published January 10, 2024 and initiated October 5, 2023. Recalling firm: Encore Medical, LP; Status: Completed; Reported quantity: 17 units; Lot: UDI: (01)00888912144612/Lot Number(s): 381P1167. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Mislabeling

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Encore Medical, LP
Distributor
US Nationwide distribution in the states of VA, TN, MN, IN, RI, ME, TX, LA, AL, FL, CA.
Lot
UDI: (01)00888912144612/Lot Number(s): 381P1167
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Reverse Shoulder System e+, REF 509-01-032, RSP Humeral Socket Insert, Sz. 32mm, Semi-Constrained, Sterile H2o2, CE 2797 recalled?

Yes. FDA published recall Z-0625-2024 on January 10, 2024. Reported hazard: Mislabeling

What should I do if I have this product?

Voluntary: Firm initiated · Letter